The Biofactory, a biomedical incubator supported by Singapore Polytechnic, aims to create successful biomedical companies from Singapore-developed technologies. Recently, it has also been recognised as an incubator under the National Research Foundation’s Technology Incubation Scheme (TIS).
The Biofactory’s key objective is to create more product-owners by bringing more Singapore-developed biomedical technologies, spin-offs and start-ups to the market. Of four start-ups established, two have been launched internationally in 2011.
IPI assisted The Biofactory in its accelerator function by first analysing its innovation needs, identifying suitable technologies and developing a product-roadmap to meet its business goals. With a clear understanding of its needs and goals, IPI assessed and validated various potential technologies in order to select suitable ones. Working in synergy with IPI, The Biofactory has been able to identify promising biomedical technologies that can be commercialised into educational, research or diagnostic kits.
“IPI is a great resource in identifying and evaluating state-of-the-art technologies to meet our business challenges,” said Theodore Tan, Director of The Biofactory. “We are also very glad that IPI has provided project-planning assistance and linked us up with various technology partners and research collaborators to further enhance our R&D capability.”
IPI also worked closely with our technology partner Exploit Technologies Pte Ltd (ETPL) to facilitate technology transfer. As a result, The Biofactory has successfully signed an agreement with ETPL to in-license and develop its technology into an Educational and a Biotech Research kit. The products are expected to be launched in some time this year. It will also continue to work with a local research institute and Singapore Polytechnic to potentially develop this technology into a diagnostic kit.
Theodore Tan added, “Through IPI’s Technology Assessment service, we are able to identify suitable technologies more quickly and effectively and focus on commercialising these technologies at an accelerated pace. We certainly will work together with IPI again for future projects”
The Biofactory’s primary objective was to increase the number of successful product-owners by bringing more Singapore-developed biomedical technologies, spin-offs, and start-ups to the market. However, the journey from technology development to commercialisation in the biomedical sector is fraught with challenges. Identifying promising technologies that are both innovative and commercially viable requires deep domain expertise, rigorous assessment, and access to a network of research and industry partners. With only four start-ups established and a goal to expand their impact, The Biofactory faced the challenge of sourcing and validating technologies that could be rapidly developed into market-ready products. The process of evaluating potential technologies, aligning them with business goals, and ensuring they could be commercialised into educational, research, or diagnostic kits demanded a strategic approach. Additionally, forming the right partnerships for technology transfer and development was essential to accelerate time-to-market and ensure successful product launches.
IPI Singapore supported The Biofactory’s accelerator function by first analysing its innovation needs, identifying suitable technologies, and developing a product roadmap aligned with its business objectives. IPI’s team worked closely with The Biofactory to gain a clear understanding of its goals and challenges, enabling a targeted approach to technology sourcing and assessment. Through its Technology Assessment service, IPI assessed and validated various potential technologies, selecting those with the highest commercialisation potential. IPI also facilitated connections with technology partners and research collaborators, including Exploit Technologies Pte Ltd (ETPL), to enable effective technology transfer. This collaborative approach empowered The Biofactory to focus on commercialising selected technologies at an accelerated pace, resulting in agreements to in-license and develop new educational and research kits.
"IPI is a great resource in identifying and evaluating state-of-the-art technologies to meet our business challenges."
"Through IPI’s Technology Assessment service, we are able to identify suitable technologies more quickly and effectively and focus on commercialising these technologies at an accelerated pace. We certainly will work together with IPI again for future projects"
The Biofactory is a biomedical incubator supported by Singapore Polytechnic, dedicated to creating successful biomedical companies from Singapore-developed technologies. Recognised as an incubator under the National Research Foundation’s Technology Incubation Scheme (TIS), The Biofactory focuses on nurturing spin-offs and start-ups to bring innovative biomedical solutions to market.